An observational study in Intracranial Aneurysm, sponsored by University Hospital, Geneva. Recruiting at 22 sites in 11 countries. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-16.
Sponsored by University Hospital, Geneva · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 21 studies in Intracranial Aneurysm with a site in Switzerland — 8 open to participants now, 9 under way, none of them phase 3. Intracranial Aneurysm · Switzerland.
Among the 21 studies in Intracranial Aneurysm with a site in Switzerland, this one is the 3rd largest by planned enrollment of the 17 observational ones that give a count, is one of 2 that started in 2015, is one of 17 observational ones, and was the 18th registered.
419 studies on the registry are indexed under Intracranial Aneurysm; 118 are open to participants now.
Browse Intracranial Aneurysm studies →8 of the 21 studies in Intracranial Aneurysm with a site in Switzerland are open now. Recruiting first, the newest first:
Phenox GmbH · Sites in Switzerland, France, Germany and 2 more countries
Insel Gruppe AG, University Hospital Bern · Sites in Switzerland
Ages 18+
Medical University of South Carolina · Sites in Switzerland, United States, Canada and 6 more countries
Ages 1–120
Nantes University Hospital · Sites in Switzerland, France, Netherlands
Ages 18+
Medtronic Neurovascular Clinical Affairs · Sites in Switzerland, Argentina, Australia and 21 more countries
Ages 18+
A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →
Of the 84 Intracranial Aneurysm studies recruiting now, 50 (60%) set no upper age limit and 15 (18%) stop at 75 or younger; 16 take children under 18; 6 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 2 started in 2015.
This study's planned enrollment of 20,000 is above the median of 200 across 191 observational studies indexed under Intracranial Aneurysm.
Median enrollment 79 across the 4 interventional studies, 572 across the 17 observational. Of the 10 that completed or were terminated, 3 (30%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 21 have an industry lead sponsor. The 10 most frequent:
University Hospital, Geneva is the lead sponsor of 379 studies on the registry; 70 are open to participants now.
University Hospital, Geneva has 2 studies filed under Intracranial Aneurysm — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 21 studies in Intracranial Aneurysm with a site in Switzerland, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The primary aim of the SwissNeuroFoundation AneurysmDataBase Project is to implement information technology based tools to create and use a holistic reference database specific to intracranial aneurysms (IA).
The SwissNeuroFoundation AneurysmDataBase are concerned with generating the data with which to populate this database.
The purpose for populating the database are to:
Clinical history, imaging data, biological samples and information derived from are the main items to be captured to the SwissNeuroFoundation AneurysmDataBase. No limits are set on the number of healthy volunteers and patient cases for whom data can be entered to the SwissNeuroFoundation AneurysmDataBase.
Participants will be recruited from the following sources:
Points of consent:
The specific items on which participants are asked to consent:
The specific items on which participants are asked to agree or disagree:
Separate specific points of consent relative to biological samples and genetics:
For the purpose of the AneurysmDataBase:
Clinical Information consists of:
Imaging Data consist of:
Samples consist of:
Prospective consecutive recruitment of cases newly diagnosed intracranial aneurysm in each participating clinical center.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients:
MRA: Magnetic Resonance Angiography CTA: Computed Tomography Angiography DSA: Digital Subtracted Angiography
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients with one or more identified intracranial aneurysm, none of which are believed to have ruptured.
Patients with one or more identified intracranial aneurysm, at least one of which has been radiologically or surgically determined to have ruptured.
Individuals selected on review of a patient's family tree and contacted by said patient, who agree to be approached for recruitment. In affected families each member will be identified as: proband, affected, unaffected, unknown, or not genetically linked.
Individuals, accompanying or contacted by a patient, or responding to open advertisement, or randomly selected in a defined population who agree to be approached for recruitment.
Disease model validation
Validation and improvement of the holistic disease model
Time frame: 5 years
Life expectancy
Age at death
Time frame: 20 years
Disability
Disease induced disability on modified Rankin scale and duration of disability
Time frame: 20 years
Cure
Absence of new treatments or bleeding after initial treatment
Time frame: 20 years
Adverse events
Aneurysm rupture after diagnosis or treatment related severe complications
Time frame: 20 years
Aneurysm growth
Observation of the growth of an aneurysm after diagnosis
Time frame: 20 years
Radiological aneurysm exclusion
Ability to completely and permanently exclude the lesion with the treatment
Time frame: 20 years
Recurrence
Recurrence or repermeabilisation of the aneurysm after treatment
Time frame: 20 years
Neo-aneurysm formation
New identification of aneurysm during follow up previously not diagnosed
Time frame: 20 years
Quality of life
regular measurement of quality of life during follow-up (i.e. EQ-5D)
Time frame: 20 years
Neuropsychological performance
regular measurement of neuropsychological performance (i.e. MMSE, MOCA, dedicated evaluation)
Time frame: 20 years
Neurological status
regular measurement of the NIHSS during follow-up
Time frame: 20 years
Cranial nerves status
regular evaluation of cranial nerve function during follow-up
Time frame: 20 years
Occurence of hydrocephalus
need for internal CSF drainage system implantation
Time frame: 20 years
Occurence of vasospasm
need for aggressive hypertensive treatment or endo-vascular rescue therapy (IA vasodilator injection, balloon angioplasty)
Time frame: 20 years
Delayed Cerebral Injury (DCI)
Radiological secondary brain injury associated to vasospasm excluding injuries associated with aneurysm intervention
Time frame: 20 years
Not enrolling at this site — choose another above.
Not enrolling at this site — choose another above.
Not enrolling at this site — choose another above.
Not enrolling at this site — choose another above.
Not enrolling at this site — choose another above.
Not enrolling at this site — choose another above.
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — Deidentified information will be made available upon justifed request and approval by the board of ADB and ethics commissions of institutions that provided data
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code
Time frame: The data will be made available to the requesting party within 3 months and for a duration of 5 years with possible extension upon request. IPD data made available to the data user shell be destroyed at the end of the data sharing agreement.
Access criteria: Any research on intracranial aneurysms
Started Jun 2015 (actual). Primary completion is estimated for Mar 2040, 297 months after the start.
Of 68 non-industry observational studies under Intracranial Aneurysm, half reached primary completion within 54 months of starting (the median), counting those still running; a quarter within 26 and three quarters within 145. This study's planned 297 months is above that.
Counting every sponsor, half of 105 studies reached it within 46 months; a quarter within 36 and three quarters within 145.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.